Study finds ProbioKid reduces infections in children during winter months
MONTREAL A study presented last month before the European Respiratory Society Annual Congress determined that the branded probiotic ProbioKid reduced infectious events in children by 25% during the winter period, as compared with a placebo. The study was conducted during the winter of 2006-2007 and involved 135 healthy, school-aged children who had suffered from at least three episodes of ear-nose-throat, bronchopulmonary or gastric disorder during the course of the previous winter.
Half of the children in the probiotic group did not develop any ENT, bronchopulmonary or gastric disorder during the winter, versus 32.9% of children in the placebo group.
ProbioKid, distributed by Institut Rosell-Lallemand, contains a combination of three probiotic strains and a prebiotic.
Hyland’s looks to have reformulated teething tablets back on the market in 2011
LOS ANGELES Hyland’s plans to have a reformulated Teething Tablets product back on the market in early 2011, the company stated, following the initiation of its voluntary recall of the product last week.
Consumer reaction to the recall overall has been supportive, Jay Borneman, Hyland’s chairman and CEO, told Drug Store News. “Our Facebook friends went up by half; the blog posts were almost three-to-one positive,” he said. From this point, Borneman said, Hyland’s will be looking to introduce an improved product offering, instituting new production protocols to ensure the consistency behind what will be a reformulated Teething Tablets product, along with incorporating child-resistant packaging.
Hyland’s experience also may serve as a case example of how to efficiently execute a recall for mid-tier companies. This marked the first product recall in Hyland’s history, Borneman said, requiring the company to acquire and put into action entirely new skill sets — such as reverse logistics, for example. “For us to react to what we had decided to do, frankly, required us in very short measure to build some fairly sophisticated competencies,” he said. “Over the course of the last couple of years, our friends over at [the Consumer Healthcare Products Association] had introduced us to a large number of people who became very important very fast in the course of managing the project,” Borneman added, enabling the company to effectively execute against its decision to recall the products.
Hyland’s recalled its Hyland’s Teething Tablets on Oct. 23 “in an abundance of caution due to an FDA investigation of its manufacturing facility,” the company stated. The company, in working with the FDA, has identified manufacturing processes of Teething Tablets that can be improved to ensure uniformity in dosage.
Adverse events have been reported, but the FDA said that a conclusive link had not been determined.
Wegmans introduces co-branded glucose monitoring system with Nipro
ROCHESTER, N.Y. Wegmans on Monday announced the availability of its co-branded blood-glucose monitoring systems: Nipro Diagnostics’ TrueResult system and True2go.
“Glucose self-monitoring, along with carbohydrate-counting, helps people with diabetes develop an everyday pattern with the best amounts and timing for food, exercise and insulin,” stated Wegmans nutrition and product labeling manager Jane Andrews. “Later on, they can use testing information to make adjustments. For example, they might check blood glucose levels just before going out for a 30-minute run, and results will help them decide how much extra carbohydrate to eat so that blood sugars don’t drop too low. "
Testing is key to staying on track, added Wegmans pharmacist Brian Pompo, coordinator of wellness and clinical services for pharmacy. “Your daily measures of blood glucose let you know if you have your diabetes under control, and give your healthcare providers the data they need to make therapy decisions.”